United States Food and Drug Administration's authorization of reduced exposure claims for IQOS®: implications for regulation in Latin America

• Main Authors: Robert Eckford (Author), Gianella Severini (Author), Ernesto M. Sebrié (Author), Monique E. Muggli (Author), Alexandra Beem (Author), Debra Rosen (Author), Eric Crosbie (Author)
• Format: Book
• Published: Pan American Health Organization, 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Philip Morris International has used the July 7, 2020 United States Food and Drug Administration's (US FDA) modified risk tobacco product order for IQOS®, which authorized certain reduced exposure marketing claims, as a corporate strategy to promote and normalize its heated tobacco products in...